SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000946
Filing Date
2021-08-05
Accepted
2021-08-05 16:26:52
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-20210630.htm   iXBRL 10-Q 2608466
2 EX-31.1 ctmx-20210630ex31_1.htm EX-31.1 16919
3 EX-31.2 ctmx-20210630ex31_2.htm EX-31.2 16883
4 EX-32.1 ctmx-20210630ex32_1.htm EX-32.1 11946
5 EX-32.2 ctmx-20210630ex32_2.htm EX-32.2 12358
  Complete submission text file 0000950170-21-000946.txt   8370506

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctmx-20210630.xsd EX-101.SCH 52256
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctmx-20210630_cal.xml EX-101.CAL 43240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctmx-20210630_pre.xml EX-101.PRE 316202
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctmx-20210630_def.xml EX-101.DEF 192710
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctmx-20210630_lab.xml EX-101.LAB 388042
11 EXTRACTED XBRL INSTANCE DOCUMENT ctmx-20210630_htm.xml XML 1474051
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 211148700
SIC: 2834 Pharmaceutical Preparations